|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/14 | |
| A61K 38/00 | |||
| A61K 38/48 |
| (11) | Number of the document | 2633860 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13165012.9 |
| Date of filing the European patent application | 2008-12-16 | |
| (97) | Date of publication of the European application | 2013-09-04 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-08 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 16230 P | 2007-12-21 | US |
| (72) |
Mankarious, Samia, US
Griffith, Michael J., US
|
| (73) |
Aptevo BioTherapeutics LLC,
2401 4th Avenue, Suite 1050, Seattle WA 98121,
US
|
| (54) | Stabilized factor IX formulations containing trehalose |
| Stabilized factor IX formulations containing trehalose |